0001694665-23-000046.txt : 20230510
0001694665-23-000046.hdr.sgml : 20230510
20230510171153
ACCESSION NUMBER: 0001694665-23-000046
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230507
FILED AS OF DATE: 20230510
DATE AS OF CHANGE: 20230510
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GILL SIMBA
CENTRAL INDEX KEY: 0001180763
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38473
FILM NUMBER: 23907624
MAIL ADDRESS:
STREET 1: 515 GALVESTON DR
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Evelo Biosciences, Inc.
CENTRAL INDEX KEY: 0001694665
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 465594527
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 620 MEMORIAL DRIVE SUITE 500
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-577-0300
MAIL ADDRESS:
STREET 1: 620 MEMORIAL DRIVE SUITE 500
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4/A
1
wf-form4a_168375309729647.xml
FORM 4/A
X0407
4/A
2023-05-07
2023-05-09
0
0001694665
Evelo Biosciences, Inc.
EVLO
0001180763
GILL SIMBA
C/O EVELO BIOSCIENCES, INC.
620 MEMORIAL DRIVE
CAMBRIDGE
MA
02139
1
1
0
0
President & CEO
0
Restricted Stock Units
2023-05-07
4
M
0
23437
0
D
Common Stock
23437.0
351563
D
Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock.
The RSUs vest in sixteen (16) substantially equal quarterly installments following the February 07, 2023 grant date, such that all of the Restricted Stock Units will become vested on the fourth anniversary of the grant date, subject to the reporting person's continued service to the issuer on each such vesting date. The RSUs have no expiration date.
This Form 4/A is being filed to disclose the disposition of 23,437 RSUs. Column 5 of Table II in the Form 4 filed on May 9, 2023 inadvertently and improperly showed that these securities were acquired. Column 9 of Table II remains unchanged from the May 9, 2023 filing.
/s/ Marella Thorell, Attorney-in-Fact for Balkrishan (Simba) Gill, Ph.D.
2023-05-10